Rapid bedside test predicts sepsis with more than 90% accuracy

Canadian scientists have developed a blood test and portable device that can determine the onset of sepsis faster and more accurately than existing methods.

Published today in Nature Communications, the test is more than 90% accurate at identifying those at high risk of developing sepsis and represents a major milestone in the way doctors will evaluate and treat sepsis.

“Sepsis accounts for roughly 20% of all global deaths,” said senior author Dr. Claudia dos Santos, a critical care physician and scientist at St. Michael’s Hospital. “Our test could be a powerful game changer, allowing physicians to quickly identify and treat patients before they begin to rapidly deteriorate.”

Sepsis is the body’s extreme reaction to an infection, causing the immune system to start attacking one’s own organs and tissues. It can lead to organ failure and death if not treated quickly. Predicting sepsis is difficult: early symptoms are non-specific, and current tests can take up to 18 hours and require specialized labs. This delay before treatment increases the chance of death by nearly eight percent per hour.

Sign up for Blog Updates